CY1106511T1 - Μεθοδος για την παρασκευη (-)cis-3-υδροξυ-1-μεθυλο-4-(2,4,6-τριμεθοξυφαινυλο)-πιπεριδινης - Google Patents
Μεθοδος για την παρασκευη (-)cis-3-υδροξυ-1-μεθυλο-4-(2,4,6-τριμεθοξυφαινυλο)-πιπεριδινηςInfo
- Publication number
- CY1106511T1 CY1106511T1 CY20071100513T CY071100513T CY1106511T1 CY 1106511 T1 CY1106511 T1 CY 1106511T1 CY 20071100513 T CY20071100513 T CY 20071100513T CY 071100513 T CY071100513 T CY 071100513T CY 1106511 T1 CY1106511 T1 CY 1106511T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methyl
- trimethoxyphenyl
- cis
- hydroxy
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19802449A DE19802449A1 (de) | 1998-01-23 | 1998-01-23 | Verfahren zur Herstellung von (-)cis-3-Hydroxy-1-methyl-4-(2,4,6-trimethoxypyhenyl)-piperidin |
| PCT/EP1998/008327 WO1999037615A1 (de) | 1998-01-23 | 1998-12-18 | Verfahren zur herstellung von (-)cis-3- hydroxy-1- methyl-4-(2, 4,6-trimethoxyphenyl)- piperidin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1106511T1 true CY1106511T1 (el) | 2012-01-25 |
Family
ID=7855418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100513T CY1106511T1 (el) | 1998-01-23 | 2007-04-12 | Μεθοδος για την παρασκευη (-)cis-3-υδροξυ-1-μεθυλο-4-(2,4,6-τριμεθοξυφαινυλο)-πιπεριδινης |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6225473B1 (show.php) |
| EP (1) | EP1049674B1 (show.php) |
| JP (1) | JP4585116B2 (show.php) |
| KR (1) | KR100567941B1 (show.php) |
| CN (1) | CN1137096C (show.php) |
| AR (1) | AR015218A1 (show.php) |
| AT (1) | ATE355270T1 (show.php) |
| AU (1) | AU762407B2 (show.php) |
| BR (1) | BR9814774B1 (show.php) |
| CA (1) | CA2318946C (show.php) |
| CY (1) | CY1106511T1 (show.php) |
| CZ (1) | CZ298852B6 (show.php) |
| DE (2) | DE19802449A1 (show.php) |
| DK (1) | DK1049674T3 (show.php) |
| ES (1) | ES2281943T3 (show.php) |
| HU (1) | HU227928B1 (show.php) |
| IL (1) | IL137422A (show.php) |
| NO (1) | NO321933B1 (show.php) |
| NZ (1) | NZ505897A (show.php) |
| PL (1) | PL190790B1 (show.php) |
| PT (1) | PT1049674E (show.php) |
| RU (1) | RU2265595C2 (show.php) |
| SK (1) | SK285883B6 (show.php) |
| TR (1) | TR200002146T2 (show.php) |
| WO (1) | WO1999037615A1 (show.php) |
| ZA (1) | ZA99477B (show.php) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6437136B2 (en) * | 1998-01-23 | 2002-08-20 | Aventis Pharma Deutschland Gmbh | Process for the preparation of (−)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)piperidine |
| DE19809649A1 (de) * | 1998-03-06 | 1999-09-09 | Hoechst Marion Roussel De Gmbh | Verfahren zur enzymatischen Enantiomeren-Trennung von 3(R)- und 3(S)-Hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydro-pyridin bzw. der Carbonsäureester |
| AU2016252609B2 (en) | 2015-04-20 | 2022-06-30 | Sumitomo Pharma Oncology, Inc. | Predicting response to alvocidib by mitochondrial profiling |
| HUE045585T2 (hu) | 2015-05-18 | 2020-01-28 | Tolero Pharmaceuticals Inc | Megnövelt biológiai hozzáférhetõséggel rendelkezõ Alvocidib gyógyszer-elõanyagok |
| AU2016301315C1 (en) | 2015-08-03 | 2022-07-07 | Sumitomo Pharma Oncology, Inc. | Combination therapies for treatment of cancer |
| WO2018094275A1 (en) | 2016-11-18 | 2018-05-24 | Tolero Pharmaceuticals, Inc. | Alvocidib prodrugs and their use as protein kinase inhibitors |
| CA3047557A1 (en) | 2016-12-19 | 2018-06-28 | Tolero Pharmaceuticals, Inc. | Profiling peptides and methods for sensitivity profiling |
| JP7196160B2 (ja) | 2017-09-12 | 2022-12-26 | スミトモ ファーマ オンコロジー， インコーポレイテッド | Ｍｃｌ－１阻害剤アルボシジブを用いた、ｂｃｌ－２阻害剤に対して非感受性である癌の治療レジメン |
| US11034710B2 (en) | 2018-12-04 | 2021-06-15 | Sumitomo Dainippon Pharma Oncology, Inc. | CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer |
| JP2022525149A (ja) | 2019-03-20 | 2022-05-11 | スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド | ベネトクラクスが失敗した急性骨髄性白血病（ａｍｌ）の処置 |
| CN110577974B (zh) * | 2019-09-10 | 2021-07-20 | 杭州澳赛诺生物科技有限公司 | 手性3-羟基-1,2,3,6-四氢吡啶的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN164232B (show.php) * | 1986-04-11 | 1989-02-04 | Hoechst India | |
| US5284856A (en) * | 1988-10-28 | 1994-02-08 | Hoechst Aktiengesellschaft | Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives |
| DE3836676A1 (de) | 1988-10-28 | 1990-05-03 | Hoechst Ag | Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel |
| US5849733A (en) * | 1996-05-10 | 1998-12-15 | Bristol-Myers Squibb Co. | 2-thio or 2-oxo flavopiridol analogs |
| US5908934A (en) | 1996-09-26 | 1999-06-01 | Bristol-Myers Squibb Company | Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs |
-
1998
- 1998-01-23 DE DE19802449A patent/DE19802449A1/de not_active Withdrawn
- 1998-12-18 WO PCT/EP1998/008327 patent/WO1999037615A1/de not_active Ceased
- 1998-12-18 KR KR1020007007959A patent/KR100567941B1/ko not_active Expired - Lifetime
- 1998-12-18 US US09/600,775 patent/US6225473B1/en not_active Expired - Lifetime
- 1998-12-18 HU HU0100649A patent/HU227928B1/hu unknown
- 1998-12-18 RU RU2000122151/04A patent/RU2265595C2/ru active
- 1998-12-18 CN CNB988132311A patent/CN1137096C/zh not_active Expired - Lifetime
- 1998-12-18 JP JP2000528539A patent/JP4585116B2/ja not_active Expired - Lifetime
- 1998-12-18 PL PL342064A patent/PL190790B1/pl unknown
- 1998-12-18 EP EP98966836A patent/EP1049674B1/de not_active Expired - Lifetime
- 1998-12-18 CZ CZ20002665A patent/CZ298852B6/cs not_active IP Right Cessation
- 1998-12-18 AU AU25135/99A patent/AU762407B2/en not_active Expired
- 1998-12-18 DK DK98966836T patent/DK1049674T3/da active
- 1998-12-18 TR TR2000/02146T patent/TR200002146T2/xx unknown
- 1998-12-18 CA CA002318946A patent/CA2318946C/en not_active Expired - Lifetime
- 1998-12-18 ES ES98966836T patent/ES2281943T3/es not_active Expired - Lifetime
- 1998-12-18 IL IL13742298A patent/IL137422A/xx not_active IP Right Cessation
- 1998-12-18 SK SK1097-2000A patent/SK285883B6/sk not_active IP Right Cessation
- 1998-12-18 BR BRPI9814774-9A patent/BR9814774B1/pt not_active IP Right Cessation
- 1998-12-18 NZ NZ505897A patent/NZ505897A/xx not_active IP Right Cessation
- 1998-12-18 AT AT98966836T patent/ATE355270T1/de active
- 1998-12-18 PT PT98966836T patent/PT1049674E/pt unknown
- 1998-12-18 DE DE59813924T patent/DE59813924D1/de not_active Expired - Lifetime
-
1999
- 1999-01-21 AR ARP990100242A patent/AR015218A1/es active IP Right Grant
- 1999-01-22 ZA ZA9900477A patent/ZA99477B/xx unknown
-
2000
- 2000-07-04 NO NO20003454A patent/NO321933B1/no not_active IP Right Cessation
-
2007
- 2007-04-12 CY CY20071100513T patent/CY1106511T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schultz et al. | Oxyfunctionalization of the remote C− H bonds of aliphatic amines by decatungstate photocatalysis | |
| Hayashi et al. | Optically active allylsilanes. 2. High stereoselectivity in asymmetric reaction with aldehydes producing homoallylic alcohols | |
| Xu et al. | Electrochemical intramolecular aminooxygenation of unactivated alkenes | |
| Chandler et al. | The Proline‐Catalyzed Double Mannich Reaction of Acetaldehyde with N‐Boc Imines | |
| Laina‐Martín et al. | Organocatalytic Strategies for the Development of the Enantioselective Inverse‐electron‐demand Hetero‐Diels‐Alder Reaction | |
| Xu et al. | Intramolecular anodic olefin coupling reactions: Use of the reaction rate to control substrate/product selectivity | |
| France et al. | Recent Developments in Catalytic, Asymmetric α‐Halogenation: A New Frontier in Asymmetric Catalysis | |
| Habert et al. | Photoinduced Aerobic Iodoarene‐Catalyzed Spirocyclization of N‐Oxy‐amides to N‐Fused Spirolactams | |
| ATE257465T1 (de) | Verfahren zur umsetzung von sauerstoffverbindungen zu olefinen mit abschreckung des produktes zur wärmegewinnung | |
| Fukuda et al. | A new strategy for catalytic Baeyer–Villiger oxidation of KA-oil with molecular oxygen using N-hydroxyphthalimide | |
| KR970069955A (ko) | 독일 반응계에서 형성된 루테늄 촉매의 존재하에 유기 화합물을 반응시키는 방법 | |
| DE59708958D1 (de) | Verfahren zur herstellung von phthaliden | |
| Dagousset et al. | Phosphoric acid catalyzed diastereo-and enantioselective synthesis of substituted 1, 3-diaminotetralins | |
| Tomooka et al. | Planar chiral dialkoxysilane: introduction of inherent chirality and high reactivity in conventional achiral alkene | |
| HUP0100649A1 (hu) | Eljárás(-)cisz-3-hidroxi-1-metil-4-(2,4,6-trimetoxi-fenil)-piperidin előállítására és az eljárás intermedierjei | |
| Meng et al. | Gold and TfOH‐Cocatalyzed Tandem Reaction of ortho‐Akynylarylaldehydes with Cyclopropenes: an Efficient Route to Functionalized Benzo [7] annulene Derivatives | |
| Alcaide et al. | A Novel One‐Step Approach for the Preparation of α‐Amino Acids, α‐Amino Amides, and Dipeptides from Azetidine‐2, 3‐diones | |
| KR900011661A (ko) | 과산화수소의 제조방법 | |
| Kuninobu et al. | Rhenium‐and Manganese‐Catalyzed Insertion of Alkynes into a Carbon–Carbon Single Bond of Cyclic and Acyclic 1, 3‐Dicarbonyl Compounds | |
| Senboku et al. | Facile synthesis of 2, 3-dihydrobenzofuran-3-ylacetic acids by novel electrochemical sequential aryl radical cyclization-carboxylation of 2-allyloxybromobenzenes using methyl 4-tert-butylbenzoate as an electron-transfer mediator | |
| Jiang et al. | Synthesis of α‐Stereogenic Amides and Ketones by Enantioselective Conjugate Addition of 1, 4‐Dicarbonyl But‐2‐enes | |
| DE3772847D1 (de) | Verfahren zur herstellung von 2-methyl-1,4-naphthochinon. | |
| Jakkampudi et al. | Diastereodivergent Synthesis of Hexahydro‐6H‐benzo [c] chromen‐6‐one Derivatives Catalyzed by Modularly Designed Organocatalysts | |
| RU2000122151A (ru) | Способ получения (-)-цис-3-гидрокси-1-метил-4-(2,4,6-триметоксифенил) пиперидина | |
| Amat et al. | Stereoselective Conjugate Addition Reactions to Phenylglycinol‐Derived, Unsaturated Oxazolopiperidone Lactams |